Skip to Main Content

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment

Conditions

Addictive Behaviors | Mental Health & Behavioral Research | Obesity & Weight Control

What is the purpose of this trial?

Brief Summary:

Brief Summary: This study will compare the effectiveness of cognitive behavioral therapy (CBT), lisdexamfetamine (LDX), and the combination of CBT and LDX for the treatment of binge-eating disorder in patients with obesity. This is an acute treatment comparing CBT or LDX alone or in combination.

  • Ages
    18 years - 64 years
  • Gender
    Both
Find out more about who can participate in this trial
  • Trial with
    National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
  • Start Date
    03/22/2019
  • End Date
    08/31/2025

For more information about this study, contact:

Valentina Ivezaj

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Sub-Investigators

  • Last Updated
    07/15/2021
  • Study HIC
    #2000022480

Contact Information

For more information about this study, including how to volunteer, contact Valentina Ivezaj

Volunteer Now